Your browser doesn't support javascript.
loading
Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Severino, Maella; Chandesris, Marie-Olivia; Barete, Stéphane; Tournier, Emilie; Sans, Béatrix; Laurent, Camille; Apoil, Pol André; Lamant, Laurence; Mailhol, Claire; Laroche, Michel; Fraitag, Sylvie; Hanssens, Katia; Dubreuil, Patrice; Hermine, Olivier; Paul, Carle; Bulai Livideanu, Cristina.
Afiliación
  • Severino M; Paul Sabatier University, Toulouse, France; Department of Dermatology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Toulouse University Hospital, Toulouse, France.
  • Chandesris MO; French Reference Center for Mastocytosis, Paris, France; Department of Hematology, Necker Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Barete S; French Reference Center for Mastocytosis, Paris, France; Unit of Dermatology, AP-HP, Pitié-Salpêtrière Hospital, Sorbonne Universities- Université Pierre et Marie CURIE (UPMC) Paris VI, Paris, France.
  • Tournier E; Paul Sabatier University, Toulouse, France; Department of Pathology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Cancer University Institute of Toulouse Oncopole, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulo
  • Sans B; Department of Dermatology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France; Toulouse University Hospital, Toulouse, France.
  • Laurent C; Paul Sabatier University, Toulouse, France; Department of Pathology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Cancer University Institute of Toulouse Oncopole, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulo
  • Apoil PA; Immunology Laboratory, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France.
  • Lamant L; Paul Sabatier University, Toulouse, France; Department of Pathology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Cancer University Institute of Toulouse Oncopole, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulo
  • Mailhol C; Department of Allergy and Pulmonology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France.
  • Laroche M; Department of Rheumatology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France.
  • Fraitag S; French Reference Center for Mastocytosis, Paris, France; Department of Pathology, Necker-Enfants Malades Hospital, AP-HP, Paris, France.
  • Hanssens K; Centre de Recherche en Cancérologie de Marseille (CRCM) (Signaling, Hematopoiesis, and Mechanism of Oncogenesis), Inserm, U1068, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 7258, Marseille, France.
  • Dubreuil P; Centre de Recherche en Cancérologie de Marseille (CRCM) (Signaling, Hematopoiesis, and Mechanism of Oncogenesis), Inserm, U1068, Institut Paoli-Calmettes, Aix-Marseille University, UM105, Centre national de la recherche scientifique (CNRS), Unité mixte de recherche (UMR) 7258, Marseille, France.
  • Hermine O; French Reference Center for Mastocytosis, Paris, France; Department of Hematology, Necker Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
  • Paul C; Paul Sabatier University, Toulouse, France; Department of Dermatology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France; Toulouse University Hospital, Toulouse, France.
  • Bulai Livideanu C; Paul Sabatier University, Toulouse, France; Department of Dermatology, Mastocytosis Competence Center of Midi-Pyrénées, Toulouse University Hospital, Toulouse, France; Mastocytosis Competence Center of Midi-Pyrénées, Toulouse, France; Toulouse University Hospital, Toulouse, France. Electronic addres
J Am Acad Dermatol ; 74(5): 885-91.e1, 2016 May.
Article en En | MEDLINE | ID: mdl-26899198
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 Problema de salud: 11_delivery_arrangements / 2_cobertura_universal Asunto principal: Telangiectasia / Urticaria Pigmentosa / Mastocitosis Sistémica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2016 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 11_ODS3_cobertura_universal / 2_ODS3 Problema de salud: 11_delivery_arrangements / 2_cobertura_universal Asunto principal: Telangiectasia / Urticaria Pigmentosa / Mastocitosis Sistémica Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Am Acad Dermatol Año: 2016 Tipo del documento: Article País de afiliación: Francia